Pharma industry on steady rebound until 2024
Pharma outsourcing not slowing down any time soon
Experts in academia, cancer research and the pharmaceutical industry have been voicing concerns over the spike of clinical trials for cancer immunotherapies, believing that many of the trials will not be completed due to a lack of participants. The increase in trials has resulted in duplicate trials being conducted, which are using up resources that […]
AI usage growing in pharma
Life science M&A deals forecast to rise in 2018, according to EY report
CRI examines surge in immuno-oncology products
NIH and pharma companies form partnership for cancer moonshot
M&A deals in biotechnology stablize
Drug companies looking at new strategies to commercialize gene therapy
Generic drugmakers look to M&A strategies to increase profits
Pay Invoice
Latest Blogs
-
SDi Forecasts Growth in Demand for Analytical Instruments 2024–2029
May 29, 2025 1:38 pm
-
NIH Disruptions and Lab Tool Companies: Stocks React
April 30, 2025 1:17 pm
-
Federal R&D Obligations for the NIH Decline in FY24
March 27, 2025 3:02 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
